Autor(es): Lince Valadares, S ; Oliveira, S ; Pires, F ; Sereno, P ; Mira, R
Data: 2016
Identificador Persistente: http://hdl.handle.net/10400.17/4157
Origem: Repositório do Centro Hospitalar de Lisboa Central, EPE
Assunto(s): Breast neoplasm; Lymph node excision; Sentinel node; Axilla; MAC GIN
Sentinel lymph node biopsy (SLNB) is the gold standard procedure for breast cancer staging and axillary lymph node dissection (AD) is recommended when metastasis are found. Two recent practice-changing studies altered this paradigm. They brought into discussion old unanswered questions, such as the impact of AD on morbidity, survival and choice of adjuvant therapy as well as new questions, like the role of radiotherapy and the omission of AD after positive SLNB. The authors reviewed the literature focusing on these issues and concluded that AD after positive SLNB can be omitted in selected cases.
